Research study on Maltese cannabis users (Still open for participants) : r/malta – Reddit
Research on maltese cannabis users research study provides crucial epidemiological data following Malta's recent legalization. This clinical analysis examines the value of Mediterranean cannabis research for evidence-based practice. Understanding usage…
Cannabis & Psychosis Study
This cannabis psychosis study examined whether cannabis and tobacco co-use predicted psychosis conversion in people already considered clinically high risk. The paper identified a concerning subgroup signal involving heavy cannabis use and light tobacco…
A Placebo-Controlled Cannabis Trial for Migraine Just Produced Real Results
A new randomized placebo-controlled trial found vaporized THC-plus-CBD cannabis improved acute migraine symptoms compared with placebo. The study represents one of the strongest migraine cannabis trials published to date. Dr. Caplan explains why…
What UK Biobank Data Suggests About Cannabis, BMI, Diabetes, and Hypertension
This cannabis metabolic health study analyzed 91,002 UK Biobank participants to explore links between cannabis use, diabetes, hypertension, and obesity risk. Researchers found lower rates of several metabolic conditions among cannabis users, but BMI…
Long-Term Cannabis Therapy May Change MS Spasticity Outcomes
Cannabis for MS spasticity was associated with meaningful symptom improvement in a new meta-analysis involving 2,544 multiple sclerosis patients across nine trials. The strongest benefits emerged with longer treatment duration, while short-term effects…
Cannabinoids & Insulin Sensitivity
CED Clinical Relevance #62 Moderate Clinical Relevance Useful mechanistic human data, but not evidence that cannabis improves metabolism in everyday life. Clinical Insight | CED Clinic This cannabinoid insulin sensitivity study shows that cannabinoid…
What the 2026 DOJ Rescheduling Order Means in Practice
On April 23, 2026, the U.S. DOJ moved state-licensed medical cannabis to Schedule III, the first federal acknowledgment of accepted medical value in 55 years. Dr. Caplan breaks down what actually changed for patients, physicians, and the research…
Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023.
A 2023 Australian survey found that cannabis users frequently report dual medical-recreational motives rather than distinct categories. This cross-sectional analysis of 3,042 adults reveals that australian medical cannabis use patterns are more nuanced…
Cannabis modalities matter for momentary subjective drug effects.
A new ecological momentary assessment study reveals that cannabis consumption method subjective effects vary significantly between delivery mechanisms. Researchers found vaporizers produced less subjective intoxication while bongs were associated with…
Daily Temporal Associations Between Use of Psychoactive Substances and Fatigue, Pain, Stress, and Depressive Symptoms in People With Multiple Sclerosis.
A real-time smartphone-based study of 258 MS patients revealed that higher pain levels drive increased cannabis use and decreased alcohol consumption. This research using ecological momentary assessment provides clinical evidence that MS patients make…